Background: There is limited information on the volume of influenza-associated mortality in Russia.
Introduction
Annual epidemics associated with the circulation of influenza A/H3N2, A/H1N1 and B take place in Russia [1] . Such epidemics are known to result in a substantial toll of mortality in other countries in the Northern Hemisphere, e.g. [2] [3] [4] [5] [6] [7] , including mortality for circulatory causes [2, 3] , with influenza additionally known to be associated with a variety of cardiovascular manifestations [8] . At the same time, there is limited information on the national burden of influenza-associated mortality in Russia. Estimates of the rates of influenza-associated mortality in Russia for select influenza seasons exist on a regional level, particularly for the city of St. Petersburg [9] . At the same time, the rates of influenza-associated mortality vary both spatially, as well as year-to-year. For example, while influenza A, particularly influenza A/H3N2 is known to be a major source of excess mortality [10] , the 2017/18 season in Europe saw high levels of excess mortality associated with the circulation of influenza B/Yamagata strains [11] , with those strains not being included in trivalent influenza vaccines. Additionally, the overall rates of death for circulatory diseases in Russia are high [12] , and there is evidence that influenza B plays an important role in influenzaassociated circulatory mortality, e.g. [13] , as well as Table 3 in [2] (comparison of regression coefficients for circulatory vs. respiratory mortality). It is important therefor to consider national data from a number of influenza seasons to address the uncertainty regarding the national burden of mortality associated with the circulation of the major influenza (sub)types (A/H3N2, A/H1N1 and B) in Russia for different causes of death, including respiratory and circulatory diseases. Such estimates are important for planning mitigation efforts, including vaccination and administration of antiviral medications to certain population groups during active circulation of the different influenza (sub)types.
In our earlier work [2, 3, 14] , we introduced a new method for estimating the burden of severe outcomes associated with influenza and the respiratory syncytial virus (RSV), designed to address several limitations of some of the previously employed inference models. An important feature of that approach is the use of RSV and influenza A/H3N2, A/H1N1, and B incidence proxies that are expected to be linearly related to the population incidence of those viruses; such proxies for influenza (sub)types combine data on medical consultations for influenza-like illness (ILI) with data on the testing of respiratory specimens from symptomatic individuals [2, 3, 7] . We've applied those incidence proxies to estimate the rates of influenza-associated mortality stratified by age/cause of death in the US [2, 3] , with the corresponding method being later adopted for the estimation of influenza-associated mortality in other countries as well, e.g. [5] [6] [7] . In this paper, we derive the corresponding proxies for the weekly/monthly incidence of influenza A/H3N2, A/H1N1, and B in Russia based on the surveillance data from the Smorodintsev Research Institute of Influenza (RII) [15] . We then apply the inference model from [2, 3, 14] to relate those incidence proxies to the monthly data from the Russian Federal State Statistics Service (Rosstat) [16] on the rates of death for respiratory causes, circulatory causes, for certain infectious and parasitic diseases, as well as the combined rates of death for five principal causes (circulatory, respiratory, certain infectious and parasitic diseases, neoplasms, diseases of the digestive system) to estimate the corresponding mortality rates associated with the circulation of the major influenza (sub)types during the 2010/11 through the 2014/15 influenza seasons in Russia.
Methods

Data
Monthly data on mortality for certain major causes of death in Russia are obtained from [16] . We'll concentrate on deaths for those causes available in [16] for which influenza is known to be a contributor [2, 3, 9] , namely respiratory deaths, circulatory deaths, deaths for certain infectious and parasitic diseases (with about 60% of the latter deaths in Russia in 2018 being HIV-related, and another 25% being TB-related, [12] ), deaths for neoplasms, and deaths for diseases of the digestive system.
Weekly data on the rates of ILI/ARI consultation per 10,000 individuals in Russia are available from [15] (with some of the data during the study period missing in [15] and can be found in the Russian language version of the Smorodintsev Institute Surveillance database [17] ). Refs. [15, 17] also contain the weekly data on the percent of respiratory specimens from symptomatic individuals that were RT-PCR positive for influenza A/H1N1, A/H3N2 and influenza B.
Inference method
Only a fraction of individuals presenting with ILI/ARI symptoms are infected with influenza. We multiplied the weekly rates of ILI/ARI consultation per 10,000 individuals [15, 17] by the weekly percentages of respiratory specimens from symptomatic individuals that were RT-PCR positive for each of influenza A/H1N1, A/H3N2 and B [15, 17] to estimate the weekly incidence proxies for each of the corresponding influenza (sub)types:
Weekly influenza (sub)type incidence proxy =
= Rate of consultations for ILI/ARI * % All respiratory specimens that were positive for the (sub)type
As noted in [2] , those proxies are expected to be proportional to the weekly population incidence for the each of the major influenza (sub)types (hence the name "proxy"). Monthly incidence proxies for influenza A/H1N1, A/H3N2 and B were obtained as the weighted average of the weekly incidence proxies for those weeks that overlapped with a given month; specifically, for each influenza (sub)type and month, the incidence proxy for each week was multiplied by the number of days in that week that were part of the corresponding month (e.g. 7 if the week was entirely within that month), then the results were summed over the different weeks and divided by the number of days in the corresponding month. Figure 1 plots the monthly incidence proxies (which are estimated as daily averages over a month) for influenza A/H1N1, A/H3N2 and B in Russia between 09/2010 and 12/2015 (64 months), with that time period chosen for inference purposes as we have information on both influenza surveillance and monthly mortality during that period [15] [16] [17] .
Earlier work (e.g. [2] ) suggests that there is a delay of up to two weeks between influenza incidence and associated mortality. For the purposes of relating influenza incidence to mortality we also considered influenza incidence proxies shifted forward by 1 or 2 weeks, with the shifted monthly incidence proxies derived from the shifted weekly incidence proxies in a manner described in the preceding paragraph. For example, the incidence proxy for a given month shifted by 2 weeks is the weighted average of the weekly incidence proxies for those weeks whose 2-week forward shift overlaps with a given month. The choice of shifting the influenza incidence proxies by 1 week, 2 weeks, or not at all in fitting the mortality data is determined by the Akaike Information Criterion (AIC) scores similarly to other choices of parameters described below.
If ( ) is the mortality rate for a given cause on month (with = 1 for 09/2010), and / 3 2( ), / 1 1( ) and ( ) are the (potentially shifted) incidence proxies for the major influenza (sub)types on month , then the inference model in [2, 3] suggests that
Here is the baseline rate of mortality not associated with influenza circulation that is periodic with yearly periodicity. To accommodate the baseline's unknown shape, we will model it as
Previous work (e.g. eTable 4 in the Supporting Information for [2] ) suggests that the estimates of influenza-associated mortality have little sensitivity to the model for the baseline, namely those estimates are very similar for the sinusoidal baseline model vs. a flexible (spline-derived) baseline model. The (temporal) trend is modeled as a low degree polynomial in time, or time periods, as explained below, with explicit model equations for respiratory mortality, circulatory mortality, mortality for certain infectious and parasitic diseases, and mortality for the selected five principal causes presented further down in this section. Additionally, Figure 1 suggests a very large incidence proxy for influenza A/H1N1 during the 2010/11 season. This may have to do with the fact that the age distribution of cases for the 2010/11 A/H1N1 epidemic was different compared to the subsequent A/H1N1 epidemics, and the ratio between the A/H1N1 incidence proxy and the rates of A/H1N1-associated mortality is potentially different for the 2010/11 season compared to later seasons.
Correspondingly, we split the A/H1N1 incidence proxy into two (one for the 2010/11 season, and one for the later seasons). The splitting is only done when justified by the Akaike Information Criterion (AIC), namely if the AIC score for the regression model drops as a result of the splitting. For the data examined in this paper, this will only be the case for deaths related to certain infectious and parasitic diseases (perhaps due to the difference in the age distribution for those deaths compared to deaths for respiratory and circulatory causes) -thus for respiratory and circulatory deaths, as well as deaths for the five selected principal causes no splitting of the A/H1N1
incidence proxy is used. The AIC is adopted to select the variables (covariates) in the model for each mortality cause, with the variable whose omission results in the largest decline in the AIC score being dropped at each step until no omissions of a variable decrease the AIC score. The model equations for respiratory mortality, circulatory mortality and mortality due to certain infectious and parasitic diseases are as follows:
Respiratory mortality. While there is no obvious long-term trend in respiratory mortality in Figure 2 , clearly there are seasonal fluctuations not related to influenza circulation, and those are likely related to the circulation of other respiratory viruses.
We will accommodate those seasonal effects by modeling the temporal trend as a function of a season, where the season for the circulation of other respiratory viruses is modeled to run from July to June. Let 1 be a linear function of the season (equaling 1 for the months of 09/2010 through 06/2011, to 2 for 07/2011 through 06/2012 etc.), 2 = 1 ! , 3 = 1 ! , etc. are the powers in 1. Then the model equation for respiratory mortality selected using the AIC criterion is:
We note that all the variables in the linear regression equation (3) are essential in the sense that removing each of them increases the AIC score of the model.
Circulatory mortality, mortality due to certain infectious and parasitic diseases, and
combined mortality due to five principal causes. Figure 2 suggests that there is a continuous downward trend in the corresponding mortality time series. Therefor, we model the trend as a low degree polynomial in the month , not the season (with that choice justified not only by the visual inspection of Figure 2 but also by the AIC criterion). We also note that the model does not yield statistically significant estimates for influenza's contribution to mortality due to neoplasms, as well as mortality due to diseases of the digestive system, though other work relying on weekly mortality data supports influenza's contribution to those causes of death [2, 3, 9] . Therefor, instead of considering those categories of deaths separately, we consider combined deaths for five principal causes (circulatory, respiratory, certain infectious and parasitic diseases, neoplasms, diseases of the digestive system). The model equations selected by the AIC criterion are:
Infectious and Parasitic disease deaths:
(here ! !"#"/!! equals to the incidence proxy for / 1 1 during the months of the 2010/11 season, and to 0 for the later months).
Five principal causes of death:
We note that a number of terms for the different influenza (sub)types are omitted by the AIC criterion for the mortality causes in eqns. (4) (5) (6) . Compared to respiratory mortality, those omissions might be related to the fact that the relative effect of influenza circulation on mortality is higher for respiratory deaths compared to the other categories of deaths; correspondingly, the effects of circulation of each influenza (sub)type on the monthly mortality are mixed with the relatively larger fluctuations in the monthly mortality counts for non-respiratory categories compared to the respiratory categories, resulting in potential lack of ascertainability as expressed by the (lack of) justification of including those covariates via the AIC score.
We also note in that regard that it is visually clear that for example the incidence proxy for influenza A/H3N2 was growing towards its peak when circulatory mortality was declining for three out of five seasons in the data, which may help explain its exclusion from the corresponding model. Given the high correlation between the incidence proxies for the different influenza (sub)types, omitting one (sub)type from the regression model affects the regression coefficients for the other (sub)types. Thus models given by eqns. (4) (5) (6) are meant to estimate the contribution of all influenza (sub)types, not only the ones included to the corresponding mortality rates, though only as the average over the study period (with annual estimates being less certain) -see also the Discussion regarding the contribution of influenza A to circulatory mortality in Russia.
Results
Figure 1 plots the monthly incidence proxies for influenza A/H1N1, A/H3N2 and B in
Russia between 09/2010 and 12/2015. Figure Respiratory deaths. Figure 3 plots the fits for the model for respiratory mortality given by eq. (3) . The fits appear to be fairly temporally consistent, with the weekly contribution of influenza to mortality estimated as the difference between the red and the green curves in Figure 3 . influenza-associated deaths due to certain infectious and parasitic diseases. We note that the estimated ratio of circulatory to respiratory influenza-associated deaths in Russia (about 2.61-to-1 Table 2 vs. Table 1 ) is quite higher that the corresponding estimate (about 1.35-to-1, [2] ) for the US. At the same time, the overall ratio of circulatory-to-respiratory deaths in Russia (about 14-to-1 in 2018, [12] ) is much higher than the corresponding ratio in the US (about 3.08-to-1 in 2017, [18] well as for the combined rates for the five principal causes of death are notably less consistent than for respiratory deaths (Figures 4 and 6 vs. 3) . For example, the major circulatory mortality peak during the 2012/13 seasons is not well-explained by the model in eq. (4). At the same time, this peak might indeed largely be not influenzaassociated as it preceded the period of high influenza circulation as described by the incidence proxies in Figure 1 , and this also applies to an extent for the 2011/12
season -see also the 2 nd paragraph of the Discussion. 
Discussion
Influenza circulation is known to be associated with substantial mortality burden in the Northern Hemisphere, e.g. [2] [3] [4] [5] [6] [7] . At the same time, there is limited information on the volume of influenza-related mortality in Russia, though some regional estimates, particularly for the city of St. Petersburg are available [9] . In this paper, we applied the previously developed methodology that was used to evaluate the rates of influenza-associated mortality in several countries, e.g. [2, 3, [5] [6] [7] [13] ). The prominence of circulatory deaths among influenza-associated mortality may be related to the overall high rates of circulatory deaths in Russia [12] . We hope that this work may help inform mitigation efforts. In particular, the role played by influenza B in the mortality burden supports the potential benefit of quadrivalent influenza vaccines (with trivalent influenza vaccines not containing the influenza B/Yamagata strains that can be a source of high levels of excess mortality [10] ). We also note in that regard that Figure 4) . At the same time, other factors might have affected those peaks in circulatory mortality. In particular, for the 2012/13 season, the peak of circulatory mortality preceded the peak periods of both influenza circulation and ILI rates.
Moreover, the peak of respiratory mortality was broader than the peak of circulatory mortality during that season (Figure 2) , with the later part of that peak in respiratory mortality explained well by influenza circulation (Figure 3 ), and the earlier part, matching temporally the peak in circulatory mortality (Figure 2) , not being explained by influenza circulation (Figure 3 ). Thus circulation of other respiratory viruses may have affected both respiratory and circulatory mortality during the 2012/13 season, and circulation of other respiratory viruses may be partly responsible for the peak(s) in circulatory mortality that were not well-explained by influenza circulation in our model. Further work involving more granular data, particularly weekly mortality data, as well as data stratified by age is needed to better understand "excess mortality" and the contribution of influenza to the mortality rates in Russia, particularly the contribution of influenza A to circulatory mortality.
We believe that despite those limitations, this work provides a national study of influenza-related mortality in Russia, giving evidence for the substantial burden of influenza-associated mortality, particularly for circulatory causes, and the contribution of influenza B to the volume of influenza-associated mortality. We hope that this work would stimulate further efforts involving more granular data (in particular, weekly mortality data, as well as data stratified by age) to better understand the effect of influenza epidemics in Russia on mortality and help inform mitigation efforts for certain population subgroups.
